SOPH
SOPHiA Genetics SA (SOPH)
Healthcare • NASDAQ • $5.15-4.63%
- Symbol
- SOPH
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Health Information Services
- Price
- $5.15
- Daily Change
- -4.63%
- Market Cap
- $369.09M
- Trailing P/E
- N/A
- Forward P/E
- -9.20
- 52W High
- $5.70
- 52W Low
- $2.59
- Analyst Target
- $8.00
- Dividend Yield
- N/A
- Beta
- 1.01
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. The company was incorporated in 2011 and is based in Rolle, Switzerland.
Company websiteResearch SOPH on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.